Robotic pancreaticoduodenectomy with a portal vein resection
Authors:
M. Rousek; P. Záruba; K. Pončáková; R. Pohnán
Authors‘ workplace:
2. LF UK a ÚVN – VFN Praha
; Chirurgická klinika
Published in:
Rozhl. Chir., 2025, roč. 104, č. 1, s. 30-34.
Category:
Case Report
doi:
https://doi.org/10.48095/ccrvch202530
Overview
Summary
Introduction: Robotic pancreaticoduodenectomy ranks among the routinely performed surgical procedures in world pancreatic centres. Since 2023, it has also been performed in the Czech Republic.
Case report: We present a case of a 65-year-old patient with accidentally found dilatation of the pancreatic duct. During the examination, a small tumor in the head of the pancreas was diagnosed. A robotic pancreaticoduodenectomy was performed. Due to the perioperative suspicion of invasion into the portal vein, the resection was performed. The operation and the course of hospitalization were uncomplicated, the patient was discharged on the 9th postoperative day.
Conclusion: Robotic pancreaticoduodenectomy is a method that combines the advantages of a minimally invasive approach and meets the requirements for safety and oncological radicality. Suspected venous invasion is not an obstacle to completing robotic surgery.
Keywords:
Pancreatic cancer – robotic pancreaticoduodenectomy – PDE – Whipple – mini-invasive pancreatic surgery
Sources
1. Giulianotti PC, Coratti A, Angelini M et al. Robotics in general surgery: personal experience in a large community hospital. Arch Surg 2003; 138(7): 777–784. doi: 10.1001/archsurg.138.7.777.
2. Boggi U, Signori S, De Lio N et al. Feasibility of robotic pancreaticoduodenectomy. Br J Surg 2013; 100(7): 917–925. doi: 10.1002/bjs.9135.
3. Watkins AA, Kent TS, Gooding WE et al. Multicenter outcomes of robotic reconstruction during the early learning curve for minimally-invasive pancreaticoduodenectomy. HPB (Oxford) 2018; 20(2): 155–165. doi: 10.1016/j.hpb.2017.08.032.
4. Shyr BU, Shyr BS, Chen SC et al. Propensity score-matched comparison of the oncological feasibility and survival outcomes for pancreatic adenocarcinoma with robotic and open pancreatoduodenectomy. Surg Endosc 2022; 36(2): 1507–1514. doi: 10.1007/s00464-021-08437-7.
5. Klotz R, Mihaljevic AL, Kulu Y et al. Robotic versus open partial pancreatoduodenectomy (EUROPA): a randomised controlled stage 2b trial. Lancet Reg Health Eur 2024; 39: 100864. doi: 10.1016/j.lanepe.2024.100864.
6. Delman AM, Whitrock JN, Turner KM et al. Defining the operative time threshold for safety in patients undergoing robotic pancreaticoduodenectomy. HPB (Oxford) 2024; 26(3): 323–332. doi: 10.1016/j.hpb.2023.11.014.
7. Benzing C, Timmermann L, Winklmann T et al. Robotic versus open pancreatic surgery: a propensity score-matched cost-effectiveness analysis. Langenbecks Arch Surg 2022; 407(5): 1923–1933. doi: 10.1007/s00423-022-02471-2.
8. Fung G, Sha M, Kunduzi B et al. Learning curves in minimally invasive pancreatic surgery: a systematic review. Langenbecks Arch Surg 2022; 407(6): 2217–2232. doi: 10.1007/s00423-022-02470-3.
9. Fakultní nemocnice Olomouc. Další úspěch olomouckých chirurgů. Robota opakovaně využili při jedné z nejnáročnějších operací slinivky břišní. [online]. Dostupné z: https://www.fnol.cz/aktuality/dalsi-uspech-olomouckych-chirurgu-robota-opakovane-vyuzili-pri-jedne-z-nejnarocnejsich-operaci-slinivky-brisni.
10. Rousek M, Záruba P, Pohnán R. Robotická pankreatická chirurgie v České republice – první zkušenosti. Gastroent Hepatol 2024; 78(2): 165–169. doi: 10.48095/ccgh2024165.
11. de Graaf N, Emmen AM, Ramera M et al. Minimally invasive versus open pancreatoduodenectomy for pancreatic and peri-ampullary neoplasm (DIPLOMA-2): study protocol for an international multicenter patient-blinded randomized controlled trial. Trials 2023; 24(1): 665. doi: 10.1186/s13063-023-07657-7.
12. Asbun HJ, Moekotte AL, Vissers FL et al. The Miami International Evidence-based Guidelines on Minimally Invasive Pancreas Resection. Ann Surg 2020; 271(1): 1–14. doi: 10.1097/SLA.0000000000003590.
13. Kauffmann EF, Napoli N, Menonna F et al. Robotic pancreatoduodenectomy with vascular resection. Langenbecks Arch Surg 2016; 401(8): 1111–1122. doi: 10.1007/s00423-016-1499-8.
14. Morelli L, Furbetta N, Palmeri M et al. Initial 50 consecutive full-robotic pancreatoduodenectomies without conversion by a single surgeon: a learning curve analysis from a tertiary referral high-volume center. Surg Endosc 2023; 37(5): 3531–3539. doi: 10.1007/s00464-022-09784-9.
15. Abu Hilal M, van Ramshorst TME, Boggi U et al. The Brescia Internationally Validated European Guidelines on Minimally Invasive Pancreatic Surgery (EGUMIPS). Ann Surg 2024; 279(1): 45–57. doi: 10.1097/SLA.0000000000006006.
16. Lof S, Vissers FL, Klompmaker S et al. Risk of conversion to open surgery during robotic and laparoscopic pancreatoduodenectomy and effect on outcomes: international propensity score-matched comparison study. Br J Surg 2021; 108(1): 80–87. doi: 10.1093/bjs/znaa026.
17. Napoli N, Kauffmann EF, Vistoli F et al. State of the art of robotic pancreatoduodenectomy. Updates Surg 2021; 73(3): 873–880. doi: 10.1007/s13304-021-01058-8.
18. van Oosten AF, Ding D, Habib JR et al. Perioperative outcomes of robotic pancreaticoduodenectomy: a propensity-matched analysis to open and laparoscopic pancreaticoduodenectomy. J Gastrointest Surg 2021; 25(7): 1795–1804. doi: 10.1007/s11605-020-04869-z.
19. Hackert T, Klaiber U, Hinz U et al. Portal vein resection in pancreatic cancer surgery: risk of thrombosis and radicality determine survival. Ann Surg 2023; 277(6): e1291–e1298. doi: 10.1097/SLA.0000000000005444.
20. Scheufele F, Hartmann D, Friess H. Treatment of pancreatic cancer-neoadjuvant treatment in borderline resectable/locally advanced pancreatic cancer. Transl Gastroenterol Hepatol 2019; 4: 32. doi: 10.21037/tgh.2019.04.09.
21. Delman AM, Whitrock JN, Turner KM et al. Defining the operative time threshold for safety in patients undergoing robotic pancreaticoduodenectomy. HPB (Oxford) 2024; 26(3): 323–332. doi: 10.1016/j.hpb.2023.11.014.
Labels
Surgery Orthopaedics Trauma surgeryArticle was published in
Perspectives in Surgery
2025 Issue 1
- Metamizole vs. Tramadol in Postoperative Analgesia
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Obstacle Called Vasospasm: Which Solution Is Most Effective in Microsurgery and How to Pharmacologically Assist It?
Most read in this issue
- Novoroční pozdrav předsedy výboru České chirurgické společnosti ČLS JEP
- Congenital lumbar hernia in a child
- Novelizace vyhlášky o vzdělávání v základních kmenech lékařů
- Robotic pancreaticoduodenectomy with a portal vein resection